ICON PLC Stock Euronext Dublin
Stocks
ICLR
IE0005711209
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
23:00:00 15/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 149.38 EUR | +645.01% |
|
-8.66% | - |
| Market Cap | 13.03B 11.29B 10.68B 9.66B 18.14B 1,250B 18.28B 127B 49.01B 634B 48.96B 47.87B 2,022B | P/E 2026 * |
28.7x | P/E 2027 * | 21.5x |
|---|---|---|---|---|---|
| Enterprise Value | 15.34B 13.28B 12.56B 11.37B 21.34B 1,471B 21.5B 150B 57.67B 746B 57.61B 56.33B 2,379B | EV / Sales 2026 * |
1.89x | EV / Sales 2027 * | 1.74x |
| Free-Float |
99.56% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ICON PLC
| 1 day | -0.50% |
| Manager | Title | Age | Since |
|---|---|---|---|
Barry Balfe
CEO | Chief Executive Officer | 48 | 01/10/2025 |
Nigel Clerkin
DFI | Director of Finance/CFO | 53 | 01/10/2024 |
Ute Berger
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
John Climax
CHM | Chairman | 73 | 01/11/2002 |
Ciaran Murray
CHM | Chairman | 63 | 01/03/2017 |
Eugene McCague
BRD | Director/Board Member | 67 | 04/10/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +645.01% | -8.66% | - | - | 13.03B | |
| +0.56% | -4.17% | -1.90% | +9.79% | 45.63B | |
| -0.12% | -2.46% | +340.09% | +529.37% | 43.96B | |
| +1.51% | +0.71% | +44.04% | +26.63% | 43.73B | |
| -2.07% | -3.28% | +6.83% | +74.56% | 40.23B | |
| -0.73% | -4.72% | +8.55% | +37.89% | 31.86B | |
| -9.49% | -11.38% | - | - | 17.4B | |
| +4.21% | +4.94% | +26.46% | +121.58% | 16.62B | |
| +1.83% | +2.63% | +15.14% | +33.31% | 14.46B | |
| -0.08% | -5.41% | +78.48% | +31.34% | 13.04B | |
| Average | -0.50% | -1.81% | +64.71% | +108.06% | 29.66B | |
| Weighted average by Cap. | -0.37% | -2.09% | +76.22% | +128.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.12B 7.03B 6.65B 6.02B 11.3B 779B 11.38B 79.36B 30.53B 395B 30.5B 29.82B 1,259B | 8.42B 7.3B 6.9B 6.25B 11.72B 808B 11.81B 82.33B 31.67B 410B 31.64B 30.94B 1,306B |
| Net income | 462M 400M 378M 343M 643M 44.32B 648M 4.52B 1.74B 22.47B 1.74B 1.7B 71.67B | 576M 499M 472M 427M 801M 55.23B 807M 5.63B 2.17B 28.01B 2.16B 2.11B 89.32B |
| Net Debt | 2.3B 1.99B 1.89B 1.71B 3.2B 221B 3.23B 22.5B 8.66B 112B 8.65B 8.46B 357B | 1.58B 1.37B 1.3B 1.18B 2.21B 152B 2.22B 15.49B 5.96B 77.07B 5.95B 5.82B 246B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ICLR Stock
- ICLR Stock
Select your edition
All financial news and data tailored to specific country editions
